# Cresud Inc: financial statements, quarterly

CRESY · Nasdaq · CIK 1034957 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cresy.md) · [Financials](/companies/cresy/financials.md) · [Filings](/companies/cresy/filings.md) · [Insiders](/companies/cresy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cresy/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-06-30) | period not labelled (2016-06-30) | period not labelled (2017-06-30) | FY2018 (2018-06-30) | FY2019 (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001615774-18-013639.md) | [33.7](/filings/0001654954-19-012197.md) | [73.0](/filings/0001654954-20-012514.md) | [85.9](/filings/0001654954-20-012514.md) | [89.3](/filings/0001654954-20-012514.md) | [152](/filings/0001568276-21-001919.md) | [45.1](/filings/0001654954-22-014335.md) | [75.3](/filings/0001654954-23-013226.md) | [145](/filings/0001654954-24-013234.md) | [160](/filings/0001654954-25-012195.md) | [251](/filings/0001654954-25-012195.md) |
| Current assets | $bn | not reported | not reported | [68.4](/filings/0001615774-18-013639.md) | [159](/filings/0001654954-19-012197.md) | [219](/filings/0001654954-20-012514.md) | [347](/filings/0001568276-21-001919.md) | [115](/filings/0001654954-22-014335.md) | [244](/filings/0001654954-23-013226.md) | [799](/filings/0001654954-24-013234.md) | [985](/filings/0001654954-25-012195.md) | [1,247](/filings/0001654954-25-012195.md) |
| Total assets | $bn | not reported | not reported | [241](/filings/0001615774-18-013639.md) | [558](/filings/0001654954-19-012197.md) | [726](/filings/0001654954-20-012514.md) | [1,032](/filings/0001568276-21-001919.md) | [556](/filings/0001654954-22-014335.md) | [1,141](/filings/0001654954-23-013226.md) | [3,973](/filings/0001654954-24-013234.md) | [4,842](/filings/0001654954-25-012195.md) | [5,089](/filings/0001654954-25-012195.md) |
| Current liabilities | $bn | not reported | not reported | [51.2](/filings/0001615774-18-013639.md) | [89.0](/filings/0001654954-19-012197.md) | [128](/filings/0001654954-20-012514.md) | [260](/filings/0001568276-21-001919.md) | [115](/filings/0001654954-22-014335.md) | [318](/filings/0001654954-23-013226.md) | [725](/filings/0001654954-24-013234.md) | [919](/filings/0001654954-25-012195.md) | [1,002](/filings/0001654954-25-012195.md) |
| Total liabilities | $bn | not reported | not reported | [192](/filings/0001615774-18-013639.md) | [434](/filings/0001654954-19-012197.md) | [599](/filings/0001654954-20-012514.md) | [848](/filings/0001568276-21-001919.md) | [383](/filings/0001654954-22-014335.md) | [695](/filings/0001654954-23-013226.md) | [2,178](/filings/0001654954-24-013234.md) | [2,664](/filings/0001654954-25-012195.md) | [2,875](/filings/0001654954-25-012195.md) |
| Shareholders' equity | $bn | [14.6](/filings/0001615774-18-013639.md) | [94.4](/filings/0001654954-19-012197.md) | [151](/filings/0001654954-20-012514.md) | [265](/filings/0001568276-21-001919.md) | [313](/filings/0001654954-22-014335.md) | [649](/filings/0001654954-23-013226.md) | [374](/filings/0001654954-23-013226.md) | [2,309](/filings/0001654954-25-012195.md) | [2,502](/filings/0001654954-25-012195.md) | [2,178](/filings/0001654954-25-012195.md) | [2,214](/filings/0001654954-25-012195.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 709,308,309 at 2025-10-14, from the cover of the [20-F filed 2026-10-21](/filings/0001654954-26-009074.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.